While most colon cancer cells express substantial amounts of CD46, samples from cancer patients show that there is an inverse correlation between CD46 expression and clinico-pathological parameters in terms of undifferentiation, invasion, metastasis, T stage, and survival, suggesting that adenoviral gene therapy may not be equally effective in patients with highly advanced colorectal cancers. This evidence concerns the gene CD46 and cancer.